Your search returned 4 results.

Results
	1.	NS-398, a selective cyclooxygenase-2 inhibitor, reduces experimental bladder carcinoma outgrowth by inhibiting tumor cell proliferation. [electronic resource] by Smakman, Niels Schaap, Nicoline Snijckers, Cristel M J T Borel Rinkes, Inne H M Kranenburg, Onno Producer: 20051128 In: Urology vol. 66 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Tumor suppression by the von Hippel-Lindau protein requires phosphorylation of the acidic domain. [electronic resource] by Lolkema, Martijn P Gervais, Michelle L Snijckers, Cristel M Hill, Richard P Giles, Rachel H Voest, Emile E Ohh, Michael Producer: 20050802 In: The Journal of biological chemistry vol. 280 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	The von Hippel-Lindau tumour suppressor interacts with microtubules through kinesin-2. [electronic resource] by Lolkema, Martijn P Mans, Dorus A Snijckers, Cristel M van Noort, Mascha van Beest, Moniek Voest, Emile E Giles, Rachel H Producer: 20071127 In: FEBS letters vol. 581 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Fibronectin is a hypoxia-independent target of the tumor suppressor VHL. [electronic resource] by Bluyssen, Hans A R Lolkema, Martijn P J K van Beest, Moniek Boone, Michelle Snijckers, Cristel M J T Los, Maartje Gebbink, Martijn F B G Braam, Branko Holstege, Frank C P Giles, Rachel H Voest, Emile E Producer: 20040308 In: FEBS letters vol. 556 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)